Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Nephrology · Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD

Monitoring Your Health and Daily Care

At a Glance

People with ADTKD-UMOD need an individualized plan to track blood pressure, kidney function, uric acid, electrolytes, and urine protein. Avoid ibuprofen or naproxen unless your clinician approves, and seek prompt care for severe dehydration, breathing trouble, very low urine, or other dangerous symptoms.

Managing ADTKD-UMOD is a long-term commitment to monitoring and self-care. Because the disease is slowly progressive and often “silent,” your daily habits and regular check-ups are important ways you and your care team can protect your kidney health [1][2].

Your Routine Surveillance Plan

While there is no “one-size-fits-all” schedule, most nephrologists recommend a monitoring plan based on your current stage of kidney disease. These check-ups are designed to catch changes early and adjust your treatment [3][4].

Vital Signs and Labs to Track

  • Blood Pressure: High blood pressure is both a symptom and a cause of kidney damage. You should monitor your pressure at home regularly, aiming for a target set by your doctor [5][6].
  • eGFR (Estimated Glomerular Filtration Rate): This is the primary measure of your kidney function. Tracking the “slope” or trend of your eGFR over months and years is more important than any single result [7][8].
  • Serum Urate (Uric Acid): Regular checks help ensure your gout medications are working. The goal is typically to keep this level below 6.0 mg/dL [7][9].
  • Electrolytes (Potassium and Bicarbonate): As kidney function declines, your body may struggle to balance these. High potassium (hyperkalemia) or acidic blood (acidosis) may require changes to your diet or medications [10][11].
  • Urine Albumin-to-Creatinine Ratio (UACR): While ADTKD-UMOD usually has low protein in the urine, checking for albuminuria (leaking protein) helps screen for other types of kidney stress, such as damage from high blood pressure or diabetes [12][13].

Day-to-Day Management

Living well with ADTKD-UMOD means making kidney-friendly choices part of your daily routine.

  • Hydration: Some patients with ADTKD-UMOD may have an impaired ability to concentrate their urine, meaning they may lose more water than average [14]. Maintaining hydration should be individualized based on your kidney, heart, and electrolyte status. Discuss this with your doctor.
  • The “No-Go” List for Pain: Most gout flares in the general population are treated with NSAIDs (like ibuprofen or naproxen). For you, these drugs can be dangerous and cause a sudden drop in kidney function [15]. Always use a personalized, pre-prescribed flare plan from your nephrologist instead of self-dosing OTC medications [16][15].
  • Diet: While a moderate restriction in calories or salt may be helpful, the most important dietary habit is consistency. Avoid high-purine foods (like organ meats or certain seafood) if they trigger your gout [17][18].

Knowing When to Call: Red Flags vs. Emergencies

It is important to distinguish between the slow, expected progression of ADTKD-UMOD and an acute problem that needs immediate attention. Do not independently stop or restart your ACE inhibitors, ARBs, diuretics, SGLT2 inhibitors, or gout medicines during an illness without following a clinician-approved sick-day plan.

Routine (Discuss at your next appointment)

  • Slow, gradual increase in fatigue (which may need evaluation for anemia or acidosis).
  • Mildly elevated uric acid levels without a gout flare.
  • Stable but slightly high blood pressure readings.

Urgent (Call your nephrologist within 24 hours)

  • A Gout Flare: Start your prescribed “emergency” flare plan and notify your doctor [9].
  • New Swelling: Swelling in the ankles, legs, or around the eyes (edema) [6].
  • Unexpected Lab Result: A notification from your clinic of a sudden drop in eGFR or a sharp rise in potassium that they asked you to monitor [19][1].

Emergency (Seek immediate care/ER)

  • Dehydration: If you have severe vomiting or diarrhea and cannot keep fluids down, your kidney function can drop rapidly [20].
  • Difficulty Breathing: This can be a sign of fluid buildup in the lungs (pulmonary edema) [6].
  • Hypertensive Emergency: Extremely high blood pressure (usually over 180/120 mmHg) accompanied by a severe headache, confusion, or chest pain [21][22].
  • Significant Decrease in Urine: If you stop producing urine or the amount decreases drastically (oliguria), this indicates a potential acute kidney injury [19][1].
  • Severe Weakness or Heart Palpitations: This can be a sign of dangerously high potassium [10].
  • Allopurinol Hypersensitivity: A new rash, fever, blistering, or facial swelling [16].
  • Atypical Joint: A hot, swollen joint accompanied by a fever (possible infection).

By staying consistent with your monitoring and knowing your body’s “normal,” you can manage ADTKD-UMOD with confidence and stay ahead of any complications.

Common questions in this guide

What should be monitored regularly with ADTKD-UMOD?
Your care plan may include home blood pressure checks and periodic eGFR, uric acid, potassium, bicarbonate, and urine albumin-to-creatinine testing. The trend in eGFR over time is usually more useful than one result, and the schedule should match your kidney disease stage.
How much water should I drink with ADTKD-UMOD?
There is no single safe amount for everyone with ADTKD-UMOD. Your fluid needs depend on kidney function, heart health, and electrolyte levels, so ask your clinician for an individualized plan, especially if you have vomiting or diarrhea.
Can I take ibuprofen for an ADTKD-UMOD gout flare?
Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen can cause a sudden decline in kidney function in people with ADTKD-UMOD. Do not self-treat with these medicines; follow the flare plan prescribed by your nephrologist or contact the office if you do not have one.
What symptoms mean I need urgent or emergency care?
Seek immediate care for severe vomiting or diarrhea that prevents drinking, trouble breathing, a major drop in urine, or very high blood pressure with severe headache, confusion, or chest pain. Severe weakness or palpitations, or a new rash, fever, blistering, or facial swelling after allopurinol also needs urgent evaluation.
What should I do if I get sick and cannot keep medicines or fluids down?
Do not independently stop or restart blood pressure, gout, diuretic, or other kidney medicines during an illness. Use the sick-day plan provided by your clinician; if you cannot keep fluids down or have severe vomiting or diarrhea, seek immediate medical care.
Does new protein or blood in my urine mean ADTKD-UMOD is worsening?
ADTKD-UMOD often causes little protein in the urine, so new protein or blood should be discussed with your clinician. It may reflect another kidney problem or a different source of stress and should not be interpreted without repeat testing and medical evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current CKD stage, and based on my eGFR slope, when do you anticipate I might need to discuss transplant options?
  2. 2.What is my target blood pressure, and how often should I be logging my home readings?
  3. 3.If I have a stomach bug and cannot keep fluids down, should I temporarily stop my blood pressure or gout medications?
  4. 4.Are there any specific 'sick day' guidelines I should follow regarding hydration or over-the-counter medications?
  5. 5.My urine is usually 'bland'; if you see protein or blood in my next test, does that mean my ADTKD-UMOD is changing or I have a different problem?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    ADTKD-UMOD in a girl with a de novo mutation: A case report.

    Li MS, Li Y, Jiang L, et al.

    Frontiers in medicine 2022; (9()):1077655 doi:10.3389/fmed.2022.1077655.

    PMID: 36606057
  2. 2

    Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

    Bonomini M, Vezzani V, Rossini M, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(10)) doi:10.3390/diagnostics16101467.

    PMID: 42196832
  3. 3

    Chronic Kidney Disease Diagnosis and Management: A Review.

    Chen TK, Knicely DH, Grams ME

    JAMA 2019; (322(13)):1294-1304 doi:10.1001/jama.2019.14745.

    PMID: 31573641
  4. 4

    Advances in the management of chronic kidney disease.

    Chen TK, Hoenig MP, Nitsch D, Grams ME

    BMJ (Clinical research ed.) 2023; (383()):e074216 doi:10.1136/bmj-2022-074216.

    PMID: 38052474
  5. 5

    Evaluating the Renal Implications of Intensive Versus Standard Blood Pressure Control in Chronic Kidney Disease: A Systematic Review of Randomized Trials.

    Lal K, Mohammad A, Tariq MU, et al.

    Cureus 2025; (17(8)):e91323 doi:10.7759/cureus.91323.

    PMID: 41035575
  6. 6

    Season-adaptive blood pressure management in older adults with CKD: a practical review.

    Furuto Y, Yoshino D, Ejima I, et al.

    Clinical and experimental nephrology 2026; (30(8)):1150-1157 doi:10.1007/s10157-026-02890-1.

    PMID: 42149344
  7. 7

    Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.

    Ayasreh N, Bullich G, Miquel R, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(3)):411-418 doi:10.1053/j.ajkd.2018.03.019.

    PMID: 29784615
  8. 8

    Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations.

    Kidd K, Vylet'al P, Schaeffer C, et al.

    Kidney international reports 2020; (5(9)):1472-1485 doi:10.1016/j.ekir.2020.06.029.

    PMID: 32954071
  9. 9

    Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.

    Olinger E, Hofmann P, Kidd K, et al.

    Kidney international 2020; (98(3)):717-731 doi:10.1016/j.kint.2020.04.038.

    PMID: 32450155
  10. 10

    Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

    Bleyer AJ, Wolf MT, Kidd KO, et al.

    Pediatric nephrology (Berlin, Germany) 2022; (37(5)):933-946 doi:10.1007/s00467-021-05118-4.

    PMID: 34021396
  11. 11

    Intact Parathyroid Hormone (iPTH) Assay: An Early Approach for Bone Health Assessment in Chronic Renal Failure.

    Kumari S, Singh PP, Kumar D, et al.

    Cureus 2024; (16(10)):e72510 doi:10.7759/cureus.72510.

    PMID: 39606517
  12. 12

    Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity.

    Chu CD, Powe NR, Shlipak MG, et al.

    BMC primary care 2022; (23(1)):299 doi:10.1186/s12875-022-01910-9.

    PMID: 36434513
  13. 13

    Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort.

    Tanaka Y, Nagano C, Sakakibara N, et al.

    Clinical and experimental nephrology 2025; (29(6)):788-796 doi:10.1007/s10157-025-02629-4.

    PMID: 39976632
  14. 14

    Genetic analysis of UMOD gene mutation in autosomal dominant tubulointerstitial kidney disease.

    Zhang Y, Li N, Lu M, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2025; (50(4)):724-730 doi:10.11817/j.issn.1672-7347.2025.240135.

    PMID: 40785686
  15. 15

    Management of Gout and Hyperuricemia in CKD.

    Vargas-Santos AB, Neogi T

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2017; (70(3)):422-439 doi:10.1053/j.ajkd.2017.01.055.

    PMID: 28456346
  16. 16

    2020 American College of Rheumatology Guideline for the Management of Gout.

    FitzGerald JD, Dalbeth N, Mikuls T, et al.

    Arthritis care & research 2020; (72(6)):744-760 doi:10.1002/acr.24180.

    PMID: 32391934
  17. 17

    Calorie Restriction Leads to Degradation of Mutant Uromodulin and Ameliorates Inflammation and Fibrosis in UMOD -Related Kidney Disease.

    Cratere MG, Perrone B, Canciani B, et al.

    Journal of the American Society of Nephrology : JASN 2026; (37(8)):1704-1719 doi:10.1681/ASN.0000001032.

    PMID: 41632531
  18. 18

    Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.

    Helget LN, Davis-Karim A, O'Dell JR, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2024; (84(5)):538-545 doi:10.1053/j.ajkd.2024.04.017.

    PMID: 38906504
  19. 19

    From Rare Disorders of Kidney Tubules to Acute Renal Injury: Progress and Prospective.

    Li J, Hou F, Lv N, et al.

    Kidney diseases (Basel, Switzerland) 2024; (10(2)):153-166 doi:10.1159/000536423.

    PMID: 38751796
  20. 20

    Altered Serum Uric Acid Levels in Kidney Disorders.

    Kim GH, Jun JB

    Life (Basel, Switzerland) 2022; (12(11)) doi:10.3390/life12111891.

    PMID: 36431026
  21. 21

    Hypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

    Chaudhry T, Sapru S

    The Brown journal of hospital medicine 2022; (1(4)):38580 doi:10.56305/001c.38580.

    PMID: 40046804
  22. 22

    An unusual presentation of UMOD-associated autosomal dominant tubulointerstitial kidney disease in a pediatric patient.

    Murray A, Cramer M

    Pediatric nephrology (Berlin, Germany) 2026; (41(3)):687-689 doi:10.1007/s00467-025-07024-5.

    PMID: 41212227

This page explains monitoring and daily care for ADTKD-UMOD for informational purposes only and does not constitute medical advice. Your nephrologist should set your testing schedule, medication plan, hydration guidance, and emergency instructions.

Get notified when new evidence is published on familial juvenile hyperuricemic nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.